Burke Rehabilitation Hospital
White Plains, New York, 10605, United States
NCT Number: NCT01820663
This phase 1 study tests whether use of the Modified Atkins Diet (MAD) can improve motor impairment after stroke. It is based on the hypothesis that after stroke, the brain's utilization of glucose, it's primary source of energy, is disrupted. The MAD is a low-carbohydrate diet that has can switch the body's metabolism from using glucose to using products of fat metabolism, so-called ketones. Ketones may act as an alternative energy substrate for the brain. Ketones also have several neuroprotective effects after stroke.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Phase 1 / Phase 2
White Plains, New York, 10605, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A high fat, high protein, low- carbohydrate diet
The control diet is a diet determined by the attending physician caring for the patient and may consist of either a low sodium diet, a low sodium/ low cholesterol diet, a regular diet or a diabetic diet.
Other names: Low sodium diet, low sodium/ low cholesterol diet, regular diet, diabetic diet
Time frame: assessed upon beginning of the study, discharge from Burke Rehabilitation Hospital (average 25 days post study enrollment) and at 3 months post discharge
The Upper Extremity Fugl Meyer Motor Score is used to assess impairment in upper extremity function. Individuals are asked to complete a certain sequence of movements, and quality of movements is scored.
Time frame: assessed upon beginning of the study, discharge from Burke Rehabilitation Hospital (average 25 days post study enrollment) and at 3 months post discharge
The MOCA is an assessment of cognitive impairment and evaluates several cognitive domains.
Burke Rehabilitation Hospital
Other
Dietary Intervention in Stroke Recovery in the Acute Rehabilitation Setting With the Modified Atkins Diet.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03684564
Antiphospholipid Syndrome, Autoimmune Diseases
Epsom, United Kingdom
View Trial DetailsNCT06249776
Brain Diseases, Brain Infarction
Ahmedabad, Gujarat, India
View Trial DetailsNCT04611906
Brain Diseases, Cardiovascular Diseases
Hong Kong
View Trial DetailsNCT06807879
Balance, Brain Diseases
Lahore, Punjab Province, Pakistan
View Trial Details